Humana Inc. (HUM) Holdings Boosted by Sei Investments Co.
Sei Investments Co. raised its stake in Humana Inc. (NYSE:HUM) by 97.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,224 shares of the insurance provider’s stock after purchasing an additional 25,808 shares during the period. Sei Investments Co.’s holdings in Humana were worth $12,723,000 as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. Koch Industries Inc. purchased a new position in Humana in the second quarter valued at approximately $404,000. Adviser Investments LLC purchased a new position in Humana in the third quarter valued at approximately $635,000. Teachers Advisors LLC increased its stake in Humana by 31.6% in the second quarter. Teachers Advisors LLC now owns 630,835 shares of the insurance provider’s stock valued at $151,792,000 after purchasing an additional 151,603 shares during the last quarter. Prisma Capital Partners LP purchased a new position in Humana in the second quarter valued at approximately $7,122,000. Finally, Federated Investors Inc. PA increased its stake in Humana by 608.1% in the second quarter. Federated Investors Inc. PA now owns 34,626 shares of the insurance provider’s stock valued at $8,331,000 after purchasing an additional 29,736 shares during the last quarter. Institutional investors own 96.15% of the company’s stock.
In other Humana news, insider Elizabeth D. Bierbower sold 9,786 shares of the business’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $259.00, for a total value of $2,534,574.00. Following the completion of the sale, the insider now directly owns 18,042 shares of the company’s stock, valued at $4,672,878. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider William Kevin Fleming sold 3,071 shares of the business’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total transaction of $770,759.58. Following the completion of the sale, the insider now directly owns 7,681 shares of the company’s stock, valued at $1,927,777.38. The disclosure for this sale can be found here. Insiders have sold a total of 20,660 shares of company stock valued at $5,319,600 over the last ninety days. 0.80% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Humana Inc. (HUM) Holdings Boosted by Sei Investments Co.” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/11/18/humana-inc-hum-holdings-boosted-by-sei-investments-co.html.
Shares of Humana Inc. (NYSE HUM) opened at $233.46 on Friday. Humana Inc. has a fifty-two week low of $186.25 and a fifty-two week high of $264.56. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61. The company has a market capitalization of $33,010.00, a price-to-earnings ratio of 20.44, a price-to-earnings-growth ratio of 1.65 and a beta of 0.90.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.27 by $0.12. Humana had a net margin of 3.49% and a return on equity of 15.99%. The company had revenue of $13.28 billion during the quarter, compared to the consensus estimate of $13.41 billion. During the same period in the previous year, the firm posted $3.18 EPS. The firm’s revenue was down 3.0% compared to the same quarter last year. equities research analysts expect that Humana Inc. will post 11.63 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio is currently 12.60%.
Several research firms have recently weighed in on HUM. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Credit Suisse Group began coverage on Humana in a report on Thursday, November 2nd. They issued a “neutral” rating and a $256.00 price objective for the company. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a report on Thursday, August 10th. UBS AG reissued a “neutral” rating and issued a $250.00 price objective (up from $237.00) on shares of Humana in a report on Wednesday, August 9th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $223.00 price objective (up from $200.00) on shares of Humana in a report on Thursday, August 3rd. Thirteen research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $252.81.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.